Overview

A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma

Status:
Recruiting
Trial end date:
2041-05-01
Target enrollment:
Participant gender:
Summary
A study that aimed to assess the safety and anti-tumor activity of CCAR031 injection in unresectable HCC patients.
Phase:
Phase 1
Details
Lead Sponsor:
Zhejiang University
Treatments:
Antibodies
Antibodies, Monoclonal
Lenvatinib